Cargando…

Parkinson’s Disease Subtypes in the Oxford Parkinson Disease Centre (OPDC) Discovery Cohort

Background: Within Parkinson’s there is a spectrum of clinical features at presentation which may represent sub-types of the disease. However there is no widely accepted consensus of how best to group patients. Objective: Use a data-driven approach to unravel any heterogeneity in the Parkinson’s phe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lawton, Michael, Baig, Fahd, Rolinski, Michal, Ruffman, Claudio, Nithi, Kannan, May, Margaret T., Ben-Shlomo, Yoav, Hu, Michele T.M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2015
Materias:	Research Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4923737/ https://www.ncbi.nlm.nih.gov/pubmed/26405788 http://dx.doi.org/10.3233/JPD-140523

Ejemplares similares

Cohort profile: the Oxford Parkinson’s Disease Centre Discovery Cohort MRI substudy (OPDC-MRI)
por: Griffanti, Ludovica, et al.
Publicado: (2020)

Statins are underused in recent-onset Parkinson's disease with increased vascular risk: findings from the UK Tracking Parkinson's and Oxford Parkinson's Disease Centre (OPDC) discovery cohorts
por: Swallow, Diane M A, et al.
Publicado: (2016)

Blood biomarkers with Parkinson's disease clusters and prognosis: The oxford discovery cohort
por: Lawton, Michael, et al.
Publicado: (2019)

Delineating nonmotor symptoms in early Parkinson's disease and first‐degree relatives
por: Baig, Fahd, et al.
Publicado: (2015)

Genetics of validated Parkinson’s disease subtypes in the Oxford Discovery and Tracking Parkinson’s cohorts
por: Lawton, Michael, et al.
Publicado: (2022)

Personality and addictive behaviours in early Parkinson's disease and REM sleep behaviour disorder
por: Baig, Fahd, et al.
Publicado: (2017)

REM sleep behaviour disorder is associated with worse quality of life and other non-motor features in early Parkinson's disease
por: Rolinski, Michal, et al.
Publicado: (2014)

Impulse control disorders in Parkinson disease and RBD: A longitudinal study of severity
por: Baig, Fahd, et al.
Publicado: (2019)

Predictors of cognitive impairment in an early stage Parkinson’s disease cohort
por: Hu, Michele T M, et al.
Publicado: (2014)

Developing and validating Parkinson’s disease subtypes and their motor and cognitive progression
por: Lawton, Michael, et al.
Publicado: (2018)

Prodromal Parkinsonism and Neurodegenerative Risk Stratification in REM Sleep Behavior Disorder
por: Barber, Thomas R, et al.
Publicado: (2017)

Predictors of motor complications in early Parkinson's disease: A prospective cohort study
por: Kelly, Mark J., et al.
Publicado: (2019)

Equating scores of the University of Pennsylvania Smell Identification Test and Sniffin' Sticks test in patients with Parkinson's disease
por: Lawton, Michael, et al.
Publicado: (2016)

Predicting motor, cognitive & functional impairment in Parkinson's
por: Lo, Christine, et al.
Publicado: (2019)

Commentary: “Association between diabetes mellitus, prediabetes and risk, disease progression of Parkinson's disease: a systematic review and meta-analysis”
por: Lawton, Michael, et al.
Publicado: (2023)

Diabetes and Neuroaxonal Damage in Parkinson's Disease
por: Vijiaratnam, Nirosen, et al.
Publicado: (2022)

Visual short-term memory deficits in REM sleep behaviour disorder mirror those in Parkinson’s disease
por: Rolinski, Michal, et al.
Publicado: (2016)

Comparison between four published definitions of hyposmia in Parkinson's disease
por: Kanavou, Sofia, et al.
Publicado: (2021)

Genetic meta-analysis of levodopa induced dyskinesia in Parkinson’s disease
por: Martinez-Carrasco, Alejandro, et al.
Publicado: (2023)

The Impact of Type 2 Diabetes in Parkinson's Disease
por: Athauda, Dilan, et al.
Publicado: (2022)

Parkinson’s Disease Subtypes: Critical Appraisal and Recommendations
por: Mestre, Tiago A., et al.
Publicado: (2021)

Features of GBA-associated Parkinson’s disease at presentation in the UK Tracking Parkinson’s study
por: Malek, Naveed, et al.
Publicado: (2018)

Identification of a possible proteomic biomarker in Parkinson’s disease: discovery and replication in blood, brain and cerebrospinal fluid
por: Winchester, Laura, et al.
Publicado: (2022)

Inflammation biomarker discovery in Parkinson’s disease and atypical parkinsonisms
por: Santaella, Anna, et al.
Publicado: (2020)

Testing Shortened Versions of Smell Tests to Screen for Hyposmia in Parkinson's Disease
por: Auger, Stephen D., et al.
Publicado: (2020)

The Opdc missense mutation of Pax2 has a milder than loss-of-function phenotype
por: Cross, Sally H., et al.
Publicado: (2011)

A composite clinical motor score as a comprehensive and sensitive outcome measure for Parkinson’s disease
por: Lo, Christine, et al.
Publicado: (2022)

Is there a subtype of developmental Parkinson's disease?
por: Riederer, P.
Publicado: (2003)

Striatal Dopamine Loss in Early Parkinson's Disease: Systematic Review and Novel Analysis of Dopamine Transporter Imaging
por: Heng, Nicholas, et al.
Publicado: (2023)

Genome-wide Analysis of Motor Progression in Parkinson Disease
por: Martínez Carrasco, Alejandro, et al.
Publicado: (2023)

Patient-centred management of Parkinson's disease
por: Grimes, David, et al.
Publicado: (2020)

Determinants of coping styles of people with Parkinson’s Disease
por: Prins, Eva M., et al.
Publicado: (2023)

Temporal orienting in Parkinson’s disease
por: Zokaei, Nahid, et al.
Publicado: (2021)

Neurophysiological Correlates of Trait Impulsivity in Parkinson’s Disease
por: Ricciardi, Lucia, et al.
Publicado: (2021)

Universal clinical Parkinson’s disease axes identify a major influence of neuroinflammation
por: Sandor, Cynthia, et al.
Publicado: (2022)

Combining biomarkers for prognostic modelling of Parkinson’s disease
por: Vijiaratnam, Nirosen, et al.
Publicado: (2022)

Aberrant functional connectivity within the basal ganglia of patients with Parkinson's disease
por: Rolinski, Michal, et al.
Publicado: (2015)

Neural and behavioral substrates of subtypes of Parkinson’s disease
por: Moustafa, Ahmed A., et al.
Publicado: (2013)

Clinical Markers of Anxiety Subtypes in Parkinson Disease
por: Broen, Martinus P. G., et al.
Publicado: (2018)

Subtyping of Parkinson’s Disease - Where Are We Up To?
por: Qian, Elizabeth, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_bjvi7k8a11bb8pt8ineiepeb65